Upload Image (Max 20MB per Image)
Nectid, a drug discovery company, has initiated clinical development of agomelatine for autism and pain indications in the US. Agomelatine, a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist, is approved for the ...
Tags: agomelatine, Nectid, major depressive disorder